A gene therapy has shown a 75% reduction in the progression of Huntington's disease in a trial. The therapy, which involves a one-time injection, has produced promising results, with some outlets describing it as a breakthrough. The developer of the therapy is expected to seek FDA approval, although the regulatory process has been tumultuous in the past.